Department of Medicine, San Francisco VA Medical Center, 4150 Clement Street,San Francisco, CA 94121, USA.
Kidney Int. 2010 Sep;78(5):478-85. doi: 10.1038/ki.2010.171. Epub 2010 Jun 2.
To evaluate the long-term consequences of acute kidney injury (AKI) in human immunodeficiency virus (HIV)-infected persons, we studied 17,325 patients in a national HIV registry during their first hospitalization. We determined the association of AKI with risk for heart failure, cardiovascular events, end-stage renal disease (ESRD), and mortality beginning 90 days after discharge. Based on AKI Network criteria, 2453 had stage 1; 273 had stage 2 or 3; and 334 had dialysis-requiring AKI. Over a mean follow-up period of 5.7 years, 333 had heart failure, 673 had cardiovascular diseases (CVDs), 348 developed ESRD, and 8405 deaths occurred. In multivariable-adjusted analyses, AKI stage 1 was associated with death and ESRD, but not heart failure or other CVD. Dialysis-requiring AKI had much stronger and significant associations with increased risk for long-term ESRD, and death in addition to heart failure and cardiovascular events. When AKI was reclassified to account for recovery, stage 1 with recovery was still associated with death, but not ESRD. Thus, in this national sample of HIV-infected persons, we found the clinical repercussions of AKI appear to extend beyond the hospital setting contributing to excess cardiovascular risks, ESRD, and mortality. Additionally, AKI affected almost one of six patients with HIV who survived at least 90 days following discharge.
为了评估人类免疫缺陷病毒(HIV)感染者急性肾损伤(AKI)的长期后果,我们对全国 HIV 登记处的 17325 名首次住院患者进行了研究。我们确定了 AKI 与心力衰竭、心血管事件、终末期肾病(ESRD)和出院后 90 天内死亡率的风险之间的关联。根据 AKI 网络标准,2453 例为 1 期;273 例为 2 期或 3 期;334 例需要透析的 AKI。在平均 5.7 年的随访期间,333 例发生心力衰竭,673 例发生心血管疾病(CVDs),348 例发展为 ESRD,8405 例死亡。在多变量调整分析中,AKI 1 期与死亡和 ESRD 相关,但与心力衰竭或其他 CVD 无关。需要透析的 AKI 与长期 ESRD 和死亡的风险增加有更强且显著的关联,此外还与心力衰竭和心血管事件相关。当 AKI 被重新分类以考虑恢复时,有恢复的 1 期仍与死亡相关,但与 ESRD 无关。因此,在这项全国性的 HIV 感染者样本中,我们发现 AKI 的临床后果似乎超出了医院环境,导致心血管风险增加、ESRD 和死亡率增加。此外,AKI 影响了近六分之一在出院后至少 90 天存活的 HIV 患者。